Rui Kitadai Yusuke Okuma Shoko Kawai
10.2147/OTT.S186213
Onco Targets Ther
2018 Dec 17;12:15-19.
alectinib anaplastic lymphoma kinase ceritinib non-small-cell lung cancer poor performance status
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/30588026/
Case Reports
PMC6301300
30588026
Ceritinib for an anaplastic lymphoma kinase rearrangement-positive patient previously treated with alectinib with poor performance status
2018